Biosimilar medicines – Multistakeholder Event
The purpose of this public event is to discuss the potential of biosimilars for health systems sustainability, and education/raising awareness towards all stakeholders.
Read the news and the documents published by the the European Commission on 30 January 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (13 février 2023). Biosimilar medicines – Multistakeholder Event. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o68b





